Category
Weight Loss Research
7 articles
GLP-1 Receptor Agonists: From Type 2 Diabetes to Metabolic Health
Tracing the research history of GLP-1 receptor agonists from their origins in diabetes treatment to their growing role in obesity and metabolic health management.
Triple Receptor Agonism: The Science Behind Retatrutide Research
An in-depth look at retatrutide's GLP-1, GIP, and glucagon receptor co-agonism, the landmark phase 2 trial data, and what triple receptor activation means for metabolic science.
Visceral Fat vs Subcutaneous Fat: Why Location Matters in Research
Not all body fat is equal. This article examines the distinct metabolic activity of visceral and subcutaneous adipose tissue, and why fat distribution — not just total weight — drives disease risk.
The Future of Weight Management: From Lifestyle to Pharmacotherapy
An evidence-based overview of the evolution of obesity treatment — from lifestyle intervention through bariatric surgery to next-generation pharmacotherapy — and what research suggests about long-term metabolic health management.
The Obesity Crisis in Australia: What the Evidence Tells Us
Australia faces a serious obesity crisis. This article examines the latest prevalence data, economic burden, and why emerging metabolic science is reshaping the research landscape.
Tirzepatide Research: The Dual GIP/GLP-1 Agonist Explained
A research-focused overview of tirzepatide's dual GIP and GLP-1 receptor mechanism, SURMOUNT trial data, and why dual agonism produces superior outcomes to single-receptor therapies.
Metabolic Syndrome: Understanding the Cluster of Conditions
A research-focused overview of metabolic syndrome — its diagnostic criteria, prevalence in Australia, and emerging evidence on peptide-based interventions targeting multiple components simultaneously.